OQS
ANIX icon

Occudo Quantitative Strategies’s Anixa Biosciences ANIX Stock Holding History

Occudo Quantitative Strategies’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,432
Closed -$40.7K – 693
2024
Q2 		$40.7K Sell
18,432
-122
-0.7% -$346 0.01% 706
2024
Q1 		$57.9K Buy
+18,554
New +$74K 0.01% 683

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MWM
Mission Wealth Management Santa Barbara, California $4.86B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Occudo Quantitative Strategies's ANIX Position: Q3 2024 in Review

Occudo Quantitative Strategies sold out of Anixa Biosciences (ANIX) in Q3 2024, closing a stake of 18,432 shares — an estimated $40.7K sold.

Occudo Quantitative Strategies first reported a position in ANIX in Q1 2024 and held it in 2 quarters. The position peaked at $57.9K in Q1 2024. 58 funds tracked by Wall St. Rank hold ANIX as of Q3 2024.

  • Occudo Quantitative Strategies reported no remaining Anixa Biosciences position as of Q3 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 18,432 Anixa Biosciences shares in Q3 2024, an estimated $40.7K.
  • Occudo Quantitative Strategies first reported a position in Anixa Biosciences in Q1 2024 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Anixa Biosciences position peaked at $57.9K in Q1 2024.
  • 58 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.